Thank you for downloading this publication. Please let us know why you chose this publication:
Why are you interested in this publication?
What organisation do you represent?
You will only need to complete this form once per browser/device
How do you prefer to read or receive publications?

We may contact you for feedback on the publication you have downloaded. If you do not want to be contacted, please leave the email field blank. Your information will never be shared with any third party.

Donate Visit Malaria Consortium U.S.
  • Visit Malaria Consortium U.S.
  • What we do
    • Diseases
    • Policy development and advocacy
    • Research
    • Learning
  • Our expertise
  • Where We Work
    • Africa
    • Burkina Faso
    • Chad
    • Ethiopia
    • Mozambique
    • Nigeria
    • South Sudan
    • Uganda
    • Asia
    • Cambodia
    • Myanmar
    • Thailand
  • Projects
    • Project database
    • Featured projects
    • Past projects
  • Publications
  • Media centre
    • Newsletters
    • News
    • Blog
    • Videos
    • Webinars
    • Press and media
    • Photo stories
    • Voices of experience
  • About us
    • Who we are
    • Governance
    • Aid transparency
    • Dr Sylvia Meek
    • Annual reviews
    • Policies and procedures
    • Careers
    • Tenders
    • Contact us
    • Malaria Consortium U.S.
  • Support us
  • Home
  • »
  • Resources
  • »
  • Publications
  • »
  • Feasibility and acceptability of extending seasonal malaria chemoprevention to children aged 5–10 years

Share this page

Resources

Latest

Publications

Publication Date:
15/07/2021

Type:
Research brief
Publication

Feasibility and acceptability of extending seasonal malaria chemoprevention to children aged 5–10 years

Publication Date:
15/07/2021
Type:
Research brief

Malaria is endemic in Chad, with a prevalence of around 41 percent in 2017. The World Health Organization recommends seasonal malaria chemoprevention (SMC) for children 3–59 months in areas of highly seasonal transmission across the Sahel. Routine household surveys conducted to evaluate coverage and quality of SMC delivery in Chad found that sulfadoxine-pyrimethamine and amodiaquine administration to children over 59 months appears to be common. 

Click here to download


Other Languages:

Télécharger en français

Country: Chad

Keywords: Capacity development | Community delivery | Child and maternal health | Policy development | Use of evidence | Malaria | Maternal, neonatal and child health | Preventive treatments | Seasonal malaria chemoprevention | SDG3

 

 

« Back to Publications

Sign up for our publications newsletter here:

Sign up for our newsletters here:

  • Visit Malaria Consortium U.S.
  • What we do
    • Diseases
    • Policy development and advocacy
    • Research
    • Learning
  • Our expertise
  • Where We Work
    • Africa
    • Burkina Faso
    • Chad
    • Ethiopia
    • Mozambique
    • Nigeria
    • South Sudan
    • Uganda
    • Asia
    • Cambodia
    • Myanmar
    • Thailand
  • Projects
    • Project database
    • Featured projects
    • Past projects
  • Publications
  • Media centre
    • Newsletters
    • News
    • Blog
    • Videos
    • Webinars
    • Press and media
    • Photo stories
    • Voices of experience
  • About us
    • Who we are
    • Governance
    • Aid transparency
    • Dr Sylvia Meek
    • Annual reviews
    • Policies and procedures
    • Careers
    • Tenders
    • Contact us
    • Malaria Consortium U.S.
  • Support us

Language Options: English | Français

© 2022 Malaria Consortium | Charity No. 1099776 | Company No. 4785712 | Privacy notice | Modern Slavery Statement | United Nations Global Compact